Metabolism of potent enkephalin analogs (FK 33–824, D-Ala2, pentafluorophenylalanine-4-enkephalinamide and a dimer of D-Ala2-enkephalin) and D-amino acid substituted derivatives of human β-endorphin
- 1 November 1978
- journal article
- research article
- Published by Elsevier in Brain Research Bulletin
- Vol. 3 (6), 687-690
- https://doi.org/10.1016/0361-9230(78)90018-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Conversion of lipotropic peptides by purified cathepsin D of human pituitary: Release of γ-endorphin by cleavage of the Leu77-PHE78 bondNeuroscience Letters, 1978
- Neuropeptides and the blood-brain barrier in goldfishPharmacology Biochemistry and Behavior, 1978
- Increased analgesic activities of a fluorinated and a dimeric analogue of [D-Ala-2]-methionine enkephalinamideBiochemical and Biophysical Research Communications, 1978
- NEUROLEPTIC-LIKE ACTIVITY OF [DES-TYR1]-γ-ENDORPHIN IN RATSThe Lancet, 1978
- Effects of the synthetic enkephalin analogue FK 33-824 in manNature, 1978
- Breakdown of enkephalin and endorphin analogs by brain extractsBrain Research Bulletin, 1977
- STRUCTURE‐FUNCTION RELATIONSHIPS IN LIPOTROPINSAnnals of the New York Academy of Sciences, 1977
- A superactive antinociceptive pentapeptide, (D‐Met2,Pro5)‐enkephalinamideFEBS Letters, 1977
- Enkephalin and a potent analog facilitate maze performance after intraperitoneal administration in ratsPharmacology Biochemistry and Behavior, 1976
- The C-Fragment of β-Lipotropin: An Endogenous Neuroleptic or Antipsychotogen?Science, 1976